Skip to content

Blog

Octus on Credit: 2025 may be marked by increased stability for large care providers but policy uncertainty looms; industry focused on addressing claim denials

Kyle Owusu, Director of Credit Research

The increased stability that large well-capitalized care providers began experiencing in the latter half of 2023 should continue through fiscal year 2025.

We envision low to mid-single digit volume and rate growth, as well as stable EBITDA margins across the care providers. In calendar year 2025 and beyond performance should be driven more by macroeconomic factors such as GDP growth and unemployment and less by the ability to manage cost spikes amidst rebounding patient volumes after covid.

Companies have successfully reduced contract labor expenses by focusing on retention and recruitment, to the detriment of the healthcare staffing companies such as AMN HealthcareIngenovis and Medical Solutions.

A lot can change though, especially with calls to reduce the Committee on Energy and Commerce’s deficit by at least $880 billion for fiscal years 2025 through 2034. The Energy and Commerce Committee oversees Medicare and Medicaid.

If there are tariffs related to medical equipment and supplies, distributors and manufacturers may seek to pass cost increases to health systems, resulting in greater supply costs for acute care providers. 

Separately, the industry remains laser focused on addressing increased prior authorization and claim denials, presenting potential opportunities for revenue cycle management companies such as Waystar.

Join us at our upcoming webinar on Feb. 26, as we discuss how investors, advisors and stakeholders should understand these dynamics, as well as others.

Receive access to these insights in real-time when you sign up for our weekly newsletter Octus on Credit.

This publication has been prepared by Octus, Inc. or one of its affiliates (collectively, "Octus") and is being provided to the recipient in connection with a subscription to one or more Octus products. Recipient’s use of the Octus platform is subject to Octus Terms of Use or the user agreement pursuant to which the recipient has access to the platform (the “Applicable Terms”). The recipient of this publication may not redistribute or republish any portion of the information contained herein other than with Octus express written consent or in accordance with the Applicable Terms. The information in this publication is for general informational purposes only and should not be construed as legal, investment, accounting or other professional advice on any subject matter or as a substitute for such advice. The recipient of this publication must comply with all applicable laws, including laws regarding the purchase and sale of securities. Octus obtains information from a wide variety of sources, which it believes to be reliable, but Octus does not make any representation, warranty, or certification as to the materiality or public availability of the information in this publication or that such information is accurate, complete, comprehensive or fit for a particular purpose. Recipients must make their own decisions about investment strategies or securities mentioned in this publication. Octus and its officers, directors, partners and employees expressly disclaim all liability relating to or arising from actions taken or not taken based on any or all of the information contained in this publication. © 2025 Octus. All rights reserved. Octus(TM) and the Octus logo are trademarks of Octus Intelligence, Inc.